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Dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis
is believed to play a key role in the pathophysiology of
depression.1 Moreover, depression and its course may be partly
genetically determined.2–5 We previously found a higher cortisol
awakening response in people with a current or a remitted major
depressive disorder.6 Together with other reports, this may
indicate that HPA axis dysregulation represents a trait rather than
a state marker.7 A similarly elevated cortisol awakening response
was observed for current panic disorder with agoraphobia.8 To
further investigate whether this dysregulation of the cortisol
morning curve represents a trait marker and whether it reflects
a biological vulnerability for, rather than a consequence (i.e. a
biological ‘scar’) of, depression or anxiety disorders it is essential to
know whether it is present before the onset of the disorder. Family
inheritance is one of the most reliable risk factors of depression.3
Recent studies have examined parental history of depression and
cortisol morning levels in people without depression, and showed
higher9 or similar levels of morning cortisol10,11 compared with
people without parental history. However, these studies had a limited
sample size, used limited morning cortisol samples, did not include
anxiety disorders or adjust for important confounders, such as
smoking or sleep duration. In addition, these studies did not
compare cortisol levels of unaffected people with those of people with
depression or anxiety disorders. Therefore, we examined differences
in 1-h awakening cortisol between unaffected people with and
without parental history of depression and/or anxiety. We included
an additional comparison group of participants with depression or
anxiety disorders and accounted for important covariates,
subthreshold symptoms, adverse childhood experiences, life events
and neuroticism.
Method
Data are from the baseline assessment (September 2004 to
February 2007) of the Netherlands Study of Depression and
Anxiety (NESDA).12 Respondents (aged 18–65) were recruited
from the community, general practice and specialised mental
healthcare services, and included people with and without
psychopathology. General exclusion criteria were: a primary
diagnosis of psychotic disorder, obsessive–compulsive disorder,
bipolar disorder or severe addiction disorder and not being fluent
in Dutch. The research protocol was approved by the Ethical
Committee of participating universities and all respondents
provided written informed consent.
Within the participants with no lifetime history of panic
disorder, generalised anxiety disorder, agoraphobia, social phobia,
major depressive disorder or dysthymia as assessed by the
DSM–IV Composite International Diagnostic Interview (CIDI
version 2.1)13 and no subthreshold symptoms (Beck Anxiety
Inventory (BAI)420,14 Inventory of Depressive Symptoms
(IDS)414)15 or use of antidepressants or benzodiazepines, three
groups were compared.
Participants without parental history
These participants reported no parental history of depression or
anxiety disorder, as assessed by the family history inventory
(n=238) on which the respondent reported on the presence of
an anxiety or depressive disorder in all individual first-degree
relatives.
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Background
It is unclear whether altered hypothalamic–pituitary–adrenal
(HPA) axis regulation, which frequently accompanies
depression and anxiety disorders, represents a trait rather
than a state factor.
Aims
To examine whether HPA axis dysregulation represents a
biological vulnerability for these disorders, we compared
cortisol levels in unaffected people with and without a
parental history of depressive or anxiety disorders. We
additionally examined whether possible HPA axis
dysregulations resemble those observed in participants with
depression or anxiety disorders.
Method
Data were from the Netherlands Study of Depression and
Anxiety. Within the participants without a lifetime diagnoses
of depression or anxiety disorders, three groups were
distinguished: 180 people without parental history, 114 with
self-reported parental history and 74 with CIDI-diagnosed
parental history. These groups were additionally compared
with people with major depressive disorder or panic disorder
with agoraphobia (n=1262). Salivary cortisol samples were
obtained upon awakening, and 30, 45 and 60 min later.
Results
As compared with unaffected participants without parental
history, unaffected individuals with diagnosed parental history
of depression or anxiety showed a significantly higher
cortisol awakening curve (effect size (d) = 0.50), which was
similar to that observed in the participants with depression
or anxiety disorders. Unaffected people with self-reported
parental history did not differ in awakening cortisol levels
from unaffected people without parental history.
Conclusions
Unaffected individuals with parental history of depression or
anxiety showed a higher cortisol awakening curve, similar to
that of the participants with depression or anxiety disorders.
This suggests that a higher cortisol awakening curve reflects
a trait marker, indicating an underlying biological vulnerability
for the development of depressive and anxiety disorders.
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Participants with self-reported parental history
These participants reported at least one biological parent with
depression and/or anxiety (n=173).
Participants with diagnosed parental history
These participants (n= 122) had previously participated in the
Adolescents at Risk of Anxiety and Depression (ARIADNE)
study16 into the development of depression and anxiety disorders
among offspring (aged 13–25) of people with psychiatric
disorders, approximately 4 years before participating in NESDA.
Parents were treated for depression or panic disorder in specialised
mental healthcare. Both offspring and parent were interviewed
with the CIDI.17
Comparison group
A comparison group of participants consisted of 2010 people who
were diagnosed with a remitted or current major depressive
disorder and/or current panic disorder with agoraphobia as
assessed by the CIDI, for whom we observed the highest cortisol
levels as compared to people without psychopathology.6,8
Exclusions and final sample
We subsequently excluded 22 pregnant or breastfeeding women
and 140 participants on corticosteroids, leaving 2381
respondents. Of these, 1630 (68.5%) returned sufficient saliva
samples: 180 (81.8%) without parental history; 114 (70.4%) with
self-reported parental history; 74 (61.7%) with diagnosed parental
history and 1262 (67.2%) with a psychiatric diagnosis, P50.001).
Salivary cortisol
A minimally intrusive way to measure basal cortisol level is
through saliva sampling, reflecting the active unbound form of
cortisol.18 As described in more detail elsewhere,19 participants
were instructed to collect saliva samples at home on a regular
(working) day shortly after the interview. Instructions concerning
saliva sampling prohibited smoking, eating, drinking tea or coffee
or brushing teeth within 15 min before sampling. Furthermore, no
dental work 24 h prior to sampling was allowed. Saliva samples
were obtained using Salivettes (Sarstedt, Germany) at four time
points; upon awakening (T1) and 30 (T2), 45 (T3) and 60 (T4)
min later. After return by mail, samples were stored at 780 8C.
Cortisol analysis was performed by competitive electrochemi-
luminescence immunoassay (E170 Roche, Switzerland). The
functional detection limit was 2.0 nmol/l and the intra- and
interassay variability coefficients in the measuring range were less
than 10%. Data cleaning excluded values 42 standard deviations
above the mean.
In addition to conducting linear mixed models analyses (see
statistical analyses section) using all four morning saliva samples,
we calculated the area under the curve with respect to the increase
(AUCi) and with respect to the ground (AUCg) using Pruessner’s
formulas.20 The AUCg is an estimate of the total cortisol secretion
over the first hour after awakening, whereas the AUCi is a measure
of the dynamic of the cortisol awakening response, more related to
the sensitivity of the system, emphasising changes over time after
awakening.21–23 If samples were collected outside of a margin of
5min around the time protocol, values were assigned missing.
Morning cortisol analyses included all participants with at least
two valid morning cortisol values (n=1630), since linear mixed
models analyses can adequately interpolate for missing data.24
For 1441 participants all four morning samples were available
and could therefore be included in the AUC analyses (158 without
parental history, 101 with self-reported parental history, 68 with
diagnosed parental history and 1114 with a psychiatric diagnosis).
Covariates
Previously, we described effects of gender, age, time of awakening,
working status, season, sleep duration, physical activity and
smoking on salivary cortisol levels,19 which were considered as
covariates. Respondents reported time of awakening and working
status on the sampling day. Season was categorised into less
(October through to February) and more daylight (March
through to September) months. Average sleep duration during
the past 4 weeks was dichotomised as 46 or 46 h/night,25 and
smoking status as current versus non-smoker. Physical activity
was assessed using the International Physical Activity
Questionnaire and expressed in 1000 MET-min (metabolic energy
turnover per min) a week.26 Menstrual cycle phase, menopausal
status or use of oral contraceptives were not associated with
salivary cortisol and were therefore not included as covariates.19
Explanatory factors
To examine whether found effects were influenced by neuroticism,
childhood trauma and life events we adjusted all analyses for these
factors. Neuroticism was measured with the 12-item subscale of
the NEO Five-Factor Inventory (NEO–FFI) Questionnaire27
ranging from 0 (low neuroticism) to 48 (high neuroticism). In
order to examine the role of earlier childhood trauma, we
constructed a cumulative childhood trauma index using the
NEMESIS childhood trauma interview,6 which summarises the
frequency of four reported traumas before the age of 16 –
emotional neglect, psychological abuse, physical abuse and sexual
abuse – resulting in an index score between 0 and 8. Finally,
negative life events in the past year were assessed by the Brugha
questionnaire28 and included 12 specific events and one ‘other’
category asking about another serious (not specified) negative life
event. Since symptom severity scores were not associated with
salivary cortisol levels in our previous studies, these were not
included as covariates.6,8
Statistical analyses
Baseline characteristics were compared using w2 and ANOVA
statistics. Area under the curves showed normal distributions,
1-h awakening cortisol levels were slightly skewed and therefore
log-transformed for linear mixed models analyses. Back-
transformed values were used in the figure. To analyse differences
in 1-h awakening cortisol across groups, ANCOVA analyses with
AUCi and AUCg were conducted. First, we compared the three
unaffected parental history groups. Additionally, parental history
groups were compared with the group of participants with a
psychiatric diagnosis. Random coefficient analysis of the four
morning cortisol levels was performed using linear mixed models,
which keeps original values on all four data points, can
accommodate for incomplete cases, and takes correlation between
repeated measurements into account.24 Parental history groups,
time point (T1, T2, T3, T4) and all covariates were entered as fixed
factors, participants were treated as a random effect and a random
intercept was estimated. To examine whether the course of cortisol
level after awakening was different across groups, we added a
group6time interaction term. For significant findings, effect sizes
were calculated with Cohen’s d. All analyses were conducted using
SPSS version 15.0 for Windows.
Results
Sample characteristics are presented in Table 1. Participants with
diagnosed parental history were younger, had later awakening
times, less often slept46 h/night, had a lower trauma index score
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and higher neuroticism scores than other unaffected participants
(Table 1). Participants with self-reported parental history reported
more childhood trauma and had higher neuroticism scores than
unaffected participants without parental history. Compared with
parents in the diagnosed parental history group, parents in the
self-reported parental history group more often had only anxiety
disorders. Diagnosed parents mostly had depression with or
without comorbid anxiety disorder.
In total 68.5% of the respondents showed an increase in
cortisol levels within 1 h of waking up (65.0% in the group
without parental history, 68.4% in the self-reported parental
history group, 77.0% in the diagnosed parental history group,
P= 0.17). Parental history groups showed significant differences in
AUCg (d.f. = 2/316, F= 3.47, P=0.03), but not in AUCi (d.f. = 2/
316, F= 1.73, P=0.18). The group with diagnosed parental history
showed higher overall adjusted cortisol levels than participants
without parental history, reflected by a larger AUCg (P= 0.01,
effect size (Cohen’s d) = 0.50, Table 2) and confirmed by a
borderline significant direct effect in linear mixed models analyses
(F= 3.39, P=0.07, data not shown). There was a trend towards a
larger AUCi (P= 0.08, d= 0.35, Table 2) for the diagnosed parental
history group, but the interaction with time was not significant
(F= 1.09, P=0.35). The group with self-reported parental history
did not show significant differences in morning cortisol compared
with the group without parental history (Table 2, linear mixed
models analyses: direct effect: F= 0.05, P=0.82; interaction with
time: F= 0.85, P= 0.47).
Additional analyses
When comparing unaffected people with diagnosed parental history
with participants with a psychiatric diagnosis, no difference was
observed (mean AUCg 20.0 (s.e.= 0.9) v. 19.5 (s.e.= 0.2) nmol/l/h,
P=0.62, mean AUCi 2.6 (s.e.= 0.8) v. 2.6 (s.e.= 0.2) nmol/l/h,
P=0.46, respectively, after full adjustment). However, this group
of participants with a psychiatric diagnosis did differ from the
group without parental history (mean AUCg 17.7 (s.e. = 0.6)
nmol/l/h, P=0.002, mean AUCi 1.4 (s.e. = 0.5) nmol/l/h,
P= 0.03) and participants with self-reported parental history
(mean AUCg 17.8 (s.e. = 0.7) nmol/l/h, P= 0.02, mean AUCi 2.1
(s.e. = 0.6) nmol/l/h, P=0.46). These results are graphically repre-
sented in Fig. 1.
Additional adjustment for childhood trauma, neuroticism and
life events in the past year did not essentially change results. In
order to conduct analyses in which age groups are more equal,
we repeated the analyses excluding all participants older than 30
years. Mean AUCg was higher for diagnosed parental history
(18.6 (s.e. = 0.8) nmol/l/h, P= 0.03, d=0.65, n=68) and also for
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Table 1 Sample characteristics












panic disorder with agoraphobia
(n=1262)
Female, % 57.8 57.0 58.1 68.1**
Age, years: mean (s.d.) 47.9 (11.8) 47.8 (11.9) 21.6 (2.7)** 43.1 (12.3)**
Time of awakening, mean (s.d.) 07.00 (1 h 11) 07.22 (1 h 02) 07.35 (1 h 11)* 07.30 (1 h 13)**
Working on day of sampling, % 65.9 65.8 64.4 55.9**
Sampling in month with more daylight,a % 56.0 48.2 50.0 54.7
46 h of sleep, % 18.1 15.8 4.1** 31.3**
Smoker, % 21.1 22.8 29.7 36.9**
Physical activity, 1000 MET-min/week: mean (s.d.) 4.0 (3.2) 3.8 (2.9) 4.1 (3.4) 3.7 (3.1)
Life event in past year, % 30.0 29.8 47.3** 39.1**
Trauma index, mean (s.d.) 0.4 (1.1) 0.9 (1.7)** 0.1 (0.3)** 1.9 (2.2)**
Neuroticism, mean (s.d.) 23.8 (5.7) 25.0 (5.7)* 28.1 (6.7)** 39.0 (7.9)**
Type of parental disorder
Anxiety only, % NA 28.1 5.9 NA
Depression only, % NA 40.4 52.9 NA
Comorbidity, % NA 31.6 41.2 NA
MET, metabolic energy turnover, NA, not applicable.
*P< 0.10, **P< 0.05 compared with unaffected participants with no parental history.
a. March through to September.

















b 17.5 (0.5) 17.6 (0.7) 0.91 19.9 (1.0) 0.07
AUCg, nmol/l/h
c 17.4 (0.5) 17.5 (0.6) 0.90 20.6 (1.0) 0.01
AUCi, nmol/l/h
b 1.0 (0.5) 1.7 (0.6) 0.38 3.1 (1.0) 0.09
AUCi, nmol/l/h
c 1.0 (0.5) 1.8 (0.6) 0.30 3.1 (1.0) 0.08
a. Area under the morning curve with respect to the ground (AUCg) = (((T1 + T2)/2)60.5)+((( T2 + T3)/2)60.25) + (((T3 + T4)/2)60.25)). Area under the morning curve with respect to
the increase (AUCi) =AUCg7(T1 (0.5 + 0.25+ 0.25)).
20
b. Adjusted for age.
c. Additionally adjusted for gender, working status, time of awakening, season, sleep, physical activity and smoking.
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self-reported parental history (17.7 (s.e.= 1.7) nmol/l/h, P=0.13,
d=0.50, n=13) compared with participants without parental
history (14.5 (s.e. = 1.5) nmol/l/h, n=20).
Since the self-reported parental history group had relatively
more parents with anxiety compared with depression or
comorbidity, we reanalysed differences only including participants
with self-reported parental depression or comorbid disorders.
Results showed a higher AUCg in the diagnosed parental history
group (mean AUCg = 20.5 (s.e. = 1.0), P= 0.01) and a similar
AUCg in the self-reported parental history group (mean
AUCg= 17.3 (s.e. = 0.8), P=0.96) as compared with controls
(mean AUCg= 17.3 (s.e. = 0.5) nmol/l/h).
Discussion
Main findings
This study shows that cortisol awakening levels in unaffected
participants with diagnosed parental history of depression or
anxiety were significantly higher than in unaffected participants
without parental history, and similar to those in participants with
major depressive disorder or panic disorder with agoraphobia.6,8
In fact, the effect size for unaffected participants with diagnosed
parental history was medium (d=0.50) and higher than the effect
sizes (d= 0.15–0.32) previously described for major depressive
disorder and panic disorder with agoraphobia.6,8 Our results
suggest that a higher cortisol awakening curve represents a trait
factor and reflects an underlying biological vulnerability marker.
The higher cortisol levels were only found in offspring of
patients with a CIDI diagnosis treated in specialised mental
healthcare and not in offspring with affected parents based on
self-report. Although often used to assess parental history, our
findings may indicate that self-report of parental psychopathology
is of insufficient reliability. Alternatively, the parents reported on
by their offspring may represent the milder cases and be associated
with lower familial loading, especially since it was not asked
whether parents were treated, in contrast to the diagnosed parents
of the ARIADNE sample for whom referral status was required for
enrolment in the study. Higher familial loading in the diagnosed
parental history group might also be reflected by the higher
neuroticism scores in this group relative to the self-reported
parental history group. In addition, when excluding participants
older than 30 years, effect sizes were higher in both parental
history groups relative to the group without parental history, also
possibly reflecting the importance of familial loading. Presumably,
and consistent with the idea that cortisol elevation represents a
liability for later onset of anxiety and depression, part of the
younger parental history group may not have developed
depression or anxiety yet. However, the older group, being still
unaffected, may never develop depression or anxiety disorder.
The larger proportion of anxiety disorder without comorbid
depression in the self-reported parental history group did not
explain the results, since additional analysis excluding anxiety
disorder without comorbid depression generated similar results.
Our results are in line with one study reporting higher
morning cortisol,9 but in contrast with studies reporting no
association with morning cortisol in unaffected people with
parental history.10,11 However, the latter two studies measured
the morning curve with only one and two saliva samples,
respectively. Participants with diagnosed parental history showed
overall higher cortisol levels (AUCg) and a trend towards a higher
increase (AUCi), indicating that especially the total cortisol
secretion within the first hour after awakening is elevated. This
emphasises the importance of collecting multiple morning
samples. The increased AUCg is possibly reflective of basal
hyperactivity of the HPA axis, since it is related to cortisol levels
during the rest of the day, whereas the AUCi is less dependent
on the diurnal cortisol rhythm and is regarded an indicator of
reactivity of the HPA axis.21–23 It has been hypothesised that the
AUCg is particularly suited to measure trait effects, whereas the
AUCi is better suited for state effects.
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An important finding was that cortisol levels were
comparable with those found in participants with a psychiatric
diagnosis. Previous studies did not compare morning cortisol
levels of individuals with familial history with people with
depression/anxiety. However, reports on cortisol release on the
dexamethasone/corticotropin-releasing hormone test showed
cortisol levels in between controls and patients.30
Genetic factors
Genetic factors could account for our findings.3,31 The cortisol
awakening response has a heritability of 32–48%31,32 and depression
has a heritability of 37%.3 It could be that the same genes underlie
both depression and morning cortisol regulation, for example the
serotonin transporter gene,33 mineralocorticoid or glucocorticoid
receptor genes.2 Epigenetic factors such as histone modification or
methylation of deoxyribonucleic acid (DNA) as a result of early
life stress could also play a role.34
Also, early childhood trauma and adversity could be more
prevalent in people growing up in families with psychiatric
problems, which may exert direct effects on inflammatory and
glucocorticoid signalling.35,36 However, adjustment for childhood
trauma, including emotional abuse, did not change our results,
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Fig. 1 Mean salivary cortisol levels for unaffected participants
without parental history, with self-reported parental history
and with diagnosed parental history and for participants with
depression or panic disorder.
Adjusted for gender, age, working status, time of awakening, sleep duration, season,
physical activity and smoking. Results of linear mixed models analyses (compared
with controls without parental history): self-reported parental history: P=0.92,
interaction with time: P=0.48. Diagnosed parental history: P=0.07 and interaction
with time: P=0.62. Personal diagnosis: P=0.01 and interaction with time: P=0.25.
Error bars illustrate standard errors. (a) P50.05 for group with personal diagnosis
compared with controls; (b) P50.05 for personal diagnosis and diagnosed parental
history compared with controls.
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Also subthreshold symptoms, as measured using the IDS or BAI
score, were not associated with salivary cortisol levels.6 Therefore,
it is unlikely that subthreshold symptoms or past traumatic events
can completely account for the relationship found in our study.
Possibly, a differential home environment due to parental
depression could have played a role, for example less structure
provided by parents37 and chronic family stress.38 Exposure to
parental depression could also have resulted in more stress among
the children, even when the depression is in remission, because of
possible personality deviances and role function problems of the
parents.39,40
Strengths and limitations
Our study had several strengths, including offspring from parents
with confirmed diagnoses, the use of four morning cortisol
samples and an additional comparison group of participants with
a psychiatric diagnosis. Moreover, we studied an adult sample,
whereas most studies included children, showing that HPA axis
dysregulations persist into adulthood. Some limitations have to
be acknowledged. First, non-adherence to the sampling
instructions could have resulted in a blunted cortisol response
after awakening.41 However, even when awakening is closely
monitored at least 15% of all participants still do not respond with
a cortisol rise.42 Moreover, we have no reason to believe that
possible non-adherence is unevenly distributed among our
groups. Second, since the majority of parents with a diagnosis
had a depressive disorder, our results are mostly restricted to
depression with or without comorbid anxiety. Future studies are
warranted to specifically examine HPA axis activity and parental
history of anxiety disorders.
Implications
Our study adds to the evidence that HPA axis alterations in
depression and anxiety represent a trait factor that may indicate
a biological vulnerability for the development of these disorders.
Therefore, the cortisol awakening curve may constitute an
important endophenotype of depression (and anxiety) for genetic
research. Although the clinical relevance of the difference in
1-hour awakening cortisol needs to be explored in further large-
scale research, there is some evidence that morning cortisol levels
predict unfavourable metabolic43 and mental health outcomes.44
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